• Home
  • Approach To Consun
    Company profile Management team Business Structure
  • Product Center
    Products Introduction Product video Nephrology series Imaging Series Women & Children Series Orthopedics Series Dermatology Series Hepatobiliary Series Gastroenterology Series Tonic Series Other Products
  • R&D Innovation
    R&D Platform R&D Team R&D Technology R&D Achievements
  • Investor Relations
    Corporate Governance Announcements & Circulars Regular Reports Documents available for inspection IR Contact
  • 中文
Investor Relations
  • Corporate Governance
  • Announcements & Circulars
  • Regular Reports
  • Documents available for inspection
  • IR Contact

Announcements & Circulars

  • 2024-11-20 Notification Letter
  • 2024-11-20 FORM OF PROXY FOR THE EXTRAORDINARY GENERAL MEETING
  • 2024-11-20 NOTICE OF EXTRAORDINARY GENERAL MEETING
  • 2024-11-20 (1) PROPOSED AMENDMENTS TO THE EXISTING MEMORANDUM AND ARTICLES OF ASSOCIATION FOR THE PAPERLESS LISTING REGIME AND ADOPTION OF THE NEW MEMORANDUM AND ARTICLES OF ASSOCIATION AND (2) NOTICE OF EGM
  • 2024-11-01 Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 October 2024
  • 2024-10-23 PROPOSED AMENDMENTS TO THE EXISTING MEMORANDUM AND ARTICLES OF ASSOCIATION FOR THE PAPERLESS LISTING REGIME AND ADOPTION OF THE NEW MEMORANDUM AND ARTICLES OF ASSOCIATION (
  • 2024-10-02 Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 September 2024
  • 2024-09-27 Notification Letter to Non-Registered Shareholders and Reply Form
  • 2024-09-27 Notification Letter to Registered Shareholders and Reply Form
  • 2024-09-09 Interim Dividend for the six months ended 30 June 2024 (
HomePrevious12345678910...69NextLast
  • Approach To Consun

    • Company profile
    • Management team
    • Business Structure
  • Product Center

    • Products Introduction
    • Product video
    • Nephrology series
    • Imaging Series
    • Women & Children Series
    • Orthopedics Series
    • Dermatology Series
    • Hepatobiliary Series
    • Gastroenterology Series
    • Tonic Series
    • Other Products
  • R&D Innovation

    • R&D Platform
    • R&D Team
    • R&D Technology
    • R&D Achievements
  • Investor Relations

    • Corporate Governance
    • Announcements & Circulars
    • Regular Reports
    • Documents available for inspection
    • IR Contact

400-930-1681

总机:(86)20-82016888

service@chinaconsun.com

71 Dongpeng Avenue, Huangpu District, Guangzhou

  • Consun

  • Health Station

  • Micro mall

工商红盾标志

Friendship Link: State Food and Drug Administration Inner Mongolia Food and Drug Administration Guangdong Food and Drug Administration Guangxi Food and Drug Administration

粤ICP备15001491号Design: uweb